Friday 17 October 2025
Home      All news      Contact us      RSS     
wn.com - 2 days ago

Can OMER stock retain Novo Nordisk driven gains over the long-term?

Omeros Corporation (NASDAQ: OMER) opened over 150% up this morning after announcing a new licensing agreement worth up to $2.1 billion with the Bagsværd-headquartered Novo Nordisk. According to OMER’s press release, this deal grants Novo exclusive global rights to develop and commercialise its MASP-3 inhibitor, zaltenibart (formerly OMS906), across all indications. At its intraday peak, Omeros stock was up nearly 300% versus its year-to-date low on Wednesday.Why OMER stock soared on Novo Nordisk...


Latest News
Hashtags:   

stock

 | 

retain

 | 

Nordisk

 | 

driven

 | 

gains

 | 

Sources